Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC28A1 | O00337 | 1/20 | 0.67 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.67 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.67 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.67 |
| ▸ | P2RY6 | Q15077 | 8/20 | 0.65 |
| ▸ | P2RY2 | P41231 | 12/20 | 0.64 |
| ▸ | P2RY4 | P51582 | 5/20 | 0.64 |
| ▸ | P2RY14 | Q15391 | 6/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2168191 | 0.93 | SLC28A1 (0.70) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL17627530 | 0.89 | SLC28A1 (0.66) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL2444841 | 0.88 | SLC28A1 (0.70) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL6053985 | 0.88 | SLC28A1 (0.74) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL24211446 | 0.87 | SLC28A1 (0.69) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL2552454 | 0.87 | SLC28A1 (0.69) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL15226209 | 0.87 | SLC28A1 (0.69) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL2635506 | 0.87 | SLC28A1 (0.69) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL2724554 | 0.87 | SLC28A1 (0.69) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 | |
| SCHEMBL4948478 | 0.87 | SLC28A1 (0.69) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0276287-B1 | SEX DETERMINATION IN RUMINANTS USING Y-CHROMOSOME SPECIFIC POLYNUCLEOTIDES | THE AUSTRALIAN NATIONAL UNIVERSITY (AU) | 1993-04-07 | — | — | EP | claimed |
| WO-1993004735-A1 | METHOD AND APPARATUS FOR RESTENOSIS TREATMENT | CEDARS-SINAI MEDICAL CENTER (US) | 1993-03-18 | — | — | WO | claimed |
| US-8492145-B2 | Process for producing nerve cells | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2013-07-23 | — | — | US | disclosed |
| WO-2012117387-A1 | METHOD OF LABELING NEURONS AND ITS APPLICATION | UNIVERSIDADE DO MINHO (PT) | 2012-09-07 | — | — | WO | disclosed |
| EP-2131825-A1 | MINERALCORTICOID RECEPTOR ANTAGONISTS FOR THE TREATMENT OF ENDOMETRIOSIS | Bayer Schering Pharma Aktiengesellschaft (DE) | 2009-12-16 | — | — | EP | disclosed |
| WO-2008107373-A1 | MINERALCORTICOID RECEPTOR ANTAGONISTS FOR THE TREATMENT OF ENDOMETRIOSIS | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2008-09-12 | — | — | WO | disclosed |
| US-20050221479-A1 | Process for producing nerve cells | TANABE SEIYAKU CO., LTD. (JP) | 2005-10-06 | — | — | US | disclosed |
| EP-1516926-A1 | PROCESS FOR PRODUCING NERVE CELLS | Tanabe Seiyaku Co., Ltd. (JP) | 2005-03-23 | — | — | EP | disclosed |
| EP-0753313-B1 | Skin substitute using marine organisms | HOKKAIDO GOVERNMENT (JP) | 2001-09-26 | — | — | EP | disclosed |
| US-5698228-A | SHEET; LAMINATION; UNCROSSLINKED COLLAGEN | HOKKAIDO GOVERNMENT (JP) | 1997-12-16 | — | — | US | disclosed |
| EP-0753313-A1 | Skin substitute using marine organisms | Hokkaido Government (JP) | 1997-01-15 | — | — | EP | disclosed |
| EP-0633786-A4 | METHOD OF INACTIVATION OF VIRAL AND BACTERIAL BLOOD CONTAMINANTS. | CRYOPHARM CORP (US) | 1995-04-19 | — | — | EP | disclosed |
| EP-0633786-A1 | METHOD OF INACTIVATION OF VIRAL AND BACTERIAL BLOOD CONTAMINANTS | BAXTER INTERNATIONAL INC. (US) | 1995-01-18 | — | — | EP | disclosed |
| WO-1993014791-A2 | METHOD OF INACTIVATION OF VIRAL AND BACTERIAL BLOOD CONTAMINANTS | CRYOPHARM CORPORATION (US) | 1993-08-05 | — | — | WO | disclosed |
| WO-1993004735-A1 | METHOD AND APPARATUS FOR RESTENOSIS TREATMENT | CEDARS-SINAI MEDICAL CENTER (US) | 1993-03-18 | — | — | WO | disclosed |